Back to MW MARSHALL WACE, LLP

DYNDYN
21 quarters

Position history for MWMARSHALL WACE, LLP's holdings in DYNE THERAPEUTICS INC

MARSHALL WACE, LLP holds 1.5M shares of DYN (DYNE THERAPEUTICS INC), worth $33.1M as of 2026-Q2. The position was increased (+1690.7% shares). DYN represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$33.1M

Current Shares

1.5M

Total Value Change

+$32.6M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.5M
+1690.7%
$33.1M0.0%$22.21
47
2026-Q1
Decreased
83,147
-87.7%
$1.5M0.0%$14.60
0
2025-Q4
Decreased
676,979
-77.5%
$13.2M0.0%$19.20
0
2025-Q3
Increased
3M
+572.9%
$38.1M0.0%$12.37
47
2025-Q2
New
447,807
-
$4.3M0.0%$9.57
37
2025-Q1
Exited
0
-100.0%
$00.0%$11.45
0
2024-Q4
New
24,501
-
$577,2430.0%$23.65
34
2024-Q3
Exited
0
-100.0%
$00.0%$33.83
0
2024-Q2
Increased
273,567
+409.4%
$9.7M0.0%$35.29
45
2024-Q1
New
53,705
-
$1.5M0.0%$28.39
35
2023-Q4
Exited
0
-100.0%
$00.0%$13.30
0
2023-Q3
Unchanged
22,052
0.0%
$197,5860.0%$8.96
0
2023-Q2
Decreased
22,052
-83.3%
$248,0850.0%$10.43
0
2023-Q1
Increased
132,344
+500.1%
$1.5M0.0%$11.58
41
2022-Q4
Decreased
22,052
-66.0%
$255,5830.0%$11.59
0
2022-Q3
Decreased
64,910
-81.4%
$824,0000.0%$12.92
0
2022-Q2
Unchanged
349,279
0.0%
$2.4M0.0%$6.70
0
2022-Q1
Unchanged
349,279
0.0%
$3.4M0.0%$9.55
0
2021-Q4
Increased
349,279
+1483.9%
$4.2M0.0%$11.95
43
2021-Q3
Unchanged
22,052
0.0%
$358,0000.0%$16.60
0
2021-Q2
New
22,052
-
$464,0000.0%$22.00
33

Other major holders of DYN: BlackRock, Inc., Janus Henderson Group Ltd., BlackRock Finance, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used